Your browser doesn't support javascript.
loading
PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.
Gezgin, Gülçin; Luk, Sietse J; Cao, Jinfeng; Dogrusöz, Mehmet; van der Steen, Dirk M; Hagedoorn, Renate S; Krijgsman, Daniëlle; van der Velden, Pieter A; Field, Matthew G; Luyten, Gregorius P M; Szuhai, Karoly; Harbour, J William; Jordanova, Ekaterina S; Heemskerk, Mirjam H M; Jager, Martine J.
Afiliación
  • Gezgin G; Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands.
  • Luk SJ; Department of Haematology, Leiden University Medical Center, Leiden, the Netherlands.
  • Cao J; Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands3Department of Ophthalmology, The Second Hospital of Jilin University, Changchun, China.
  • Dogrusöz M; Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands.
  • van der Steen DM; Department of Haematology, Leiden University Medical Center, Leiden, the Netherlands.
  • Hagedoorn RS; Department of Haematology, Leiden University Medical Center, Leiden, the Netherlands.
  • Krijgsman D; Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands.
  • van der Velden PA; Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands.
  • Field MG; Bascom Palmer Eye Institute, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida.
  • Luyten GPM; Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands.
  • Szuhai K; Department of Molecular Cell Biology, Leiden University Medical Center, Leiden, the Netherlands.
  • Harbour JW; Bascom Palmer Eye Institute, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida.
  • Jordanova ES; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands7Center for Gynecological Oncology Amsterdam, Department of Obstetrics and Gynecology, VU University Medical Center, Amsterdam, the Netherlands.
  • Heemskerk MHM; Department of Haematology, Leiden University Medical Center, Leiden, the Netherlands.
  • Jager MJ; Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands.
JAMA Ophthalmol ; 135(6): 541-549, 2017 06 01.
Article en En | MEDLINE | ID: mdl-28448663
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Úvea / ADN de Neoplasias / Regulación Neoplásica de la Expresión Génica / Inmunoterapia / Melanoma / Antígenos de Neoplasias Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Ophthalmol Año: 2017 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Úvea / ADN de Neoplasias / Regulación Neoplásica de la Expresión Génica / Inmunoterapia / Melanoma / Antígenos de Neoplasias Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Ophthalmol Año: 2017 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos